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Purpose: The retinal pigment epithelium (RPE) is a main target for complement 
activation in age-related macular degeneration (AMD). The anaphylatoxins C3a and C5a 
have been thought to mostly play a role as chemoattractants for macrophages and 
immune cells; here, we explore whether they trigger RPE alterations. Specifically, we 
investigated the RPE as a potential immunoregulatory gate, allowing for active changes 
in the RPE microenvironment in response to complement.
Design: In vitro and in vivo analysis of signaling pathways.
Methods: Individual activities of and interaction between the two anaphylatoxin recep-
tors were tested in cultured RPE cells by fluorescence microscopy, western blot, and 
immunohistochemistry.
Main outcome measures: Intracellular free calcium, protein phosphorylation, immu-
nostaining of tissues/cells, and multiplex secretion assay.
results: Similar to immune cells, anaphylatoxin exposure resulted in increases in free 
cytosolic Ca2+, PI3-kinase/Akt activation, FoxP3 and FOXO1 phosphorylation, and cyto-
kine/chemokine secretion. Differential responses were elicited depending on whether 
C3a and C5a were co-administered or applied consecutively, and response amplitudes in 
co-administration experiments ranged from additive to driven by C5a (C3a + C5a = C5a) 
or being smaller than those elicited by C3a alone (C3a + C5a < C3a).
conclusion: We suggest that this combination of integrative signaling between C3aR 
and C5aR helps the RPE to precisely adopt its immune regulatory function. These data 
further contribute to our understanding of AMD pathophysiology.
Keywords: anaphylatoxins, calcium signaling, FOXO1, FoxP3, retinal pigment epithelium
inTrODUcTiOn
The retinal pigment epithelium (RPE) is a monolayer of pigmented cells located between the light-
sensitive photoreceptors and the fenestrated endothelium of the choriocapillaris (1). The RPE’s central 
role in retinoid metabolism and outer segment phagocytosis makes it a close interaction partner of 
the photoreceptors in visual function. It forms a tight epithelium that separates the neural retina 
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from the blood stream. The RPE, which is regarded as part of 
the outer blood–retina barrier (1, 2), also actively establishes a 
barrier for immune reactions by forming, on one hand, a physi-
cal barrier for immune cells and, on the other hand, by secret-
ing immunomodulatory factors as well as expressing surface 
receptors to interact with immune cells. Due to the expression 
of these immunomodulatory mediators, the RPE is regarded as 
an “educational” or “immunoregulatory” gate, since immune cells 
that pass through the fenestrated capillaries of the choroid, upon 
interacting with the outer blood–retina barrier, are skewed toward 
a regulatory and pro-resolving phenotype (3).
A coordinated immune suppression requires the RPE’s ability 
to “sense” immune or inflammatory activities. For that purpose, 
the RPE expresses a large variety of plasma membrane receptors 
in a very similar manner to that of immune cells, including Toll-
like receptors (4) and cytokine receptors such as the receptor for 
tumor-necrosis factor-α (5) and the CXC-chemokine receptor 4 
(6–8). In addition, the native RPE expresses complement recep-
tors C3aR and C5aR to respond to the anaphylatoxins C3a and 
C5a (9–11). Anaphylatoxins are soluble components produced as 
part of the activation of the common pathway of the complement 
system, which culminates in the generation of the cell-killing ter-
minal complement complex (TCC) or membrane attack complex 
(MAC). A variety of complement-induced functional changes 
in the RPE has been reported. C5a induces vascular endothelial 
growth-factor-A (VEGF-A) production (12) and serves as a prim-
ing signal for the formation of the NLRP3 inflammasome (13), 
and sub-lytic concentrations of the TCC/MAC induce VEGF-A 
secretion by the RPE (14–17). The ability of the RPE to modulate 
complement activation on its cell surface, preventing a lytic as well 
as rapidly terminating a sub-lytic MAC attack, is due to the RPE 
expressing or recruiting various complement inhibitors to its cell 
surface (18) and is supported by our recent findings demonstrat-
ing that normal human serum (NHS) as a source of complement is 
unable to form a lytic pore in the RPE cell plasma membrane (19). 
Instead of forming a membrane pore to allow Ca2+ to enter the 
RPE cell, complement activation increases intracellular free Ca2+ 
as a second messenger by activating ion channels, among them the 
Ca2+-dependent K+ channel Maxi-K and the voltage-dependent 
L-type Ca2+ channel. The latter becomes constitutively activated 
by phosphorylation and mediates VEGF-A secretion by the RPE 
(15). Thus, taken together, the three major biological effectors 
of the complement cascade, C3a, C5a, and TCC, appear to con-
tribute differentially to complement-evoked RPE cell signaling. 
Finally, the complement–RPE interaction has attracted consider-
able attention in research on the pathomechanisms of age-related 
macular degeneration (AMD). Evidence derived from genetic 
analyses revealed that polymorphisms in genes for complement 
factors are associated with an increased risk for developing AMD 
(20–23). Furthermore, proteomics and immunohistochemical 
analyses demonstrated accumulation of complement proteins, 
including C3a and C5a, in drusen that are localized between the 
RPE and Bruch’s membrane (24–26), indicating that anaphyla-
toxin/RPE interactions are also involved in AMD pathogenesis.
Intracellular anaphylatoxin signaling mechanisms in the 
RPE have so far not been investigated in detail. Recent data on 
anaphylatoxin signaling in T-cells revealed new functional roles 
for the complement system (27, 28), whereby stimulation of 
anaphylatoxin receptors in the plasma membrane moves T-cell 
differentiation toward a Th1 phenotype by phosphorylation of 
forkhead box protein O1 (FoxO1). This leads to a reduction of 
forkhead box P3 (FoxP3) expression, a transient marker for acti-
vated T-cells and a permanent marker for regulator (Treg) T-cells 
(29–32). In T-cells, C3a and C5a show additive effects on FoxP3 
suppression. Furthermore, in those cells, an intracellular function 
for complement C3a was discovered (28, 33, 34).
In this study, we hypothesize that anaphylatoxins lead to changes 
in the functional phenotype of RPE cells rather than resulting in 
degeneration. Our study reports that the signaling pathways initi-
ated by C3a or C5a lead to changes in Ca2+ signaling, triggering 
kinase-dependent pathways, activation of transcription factors, 
and alterations in gene expression and cytokine secretion. 
Importantly, we uncovered interactions between C3a- and C5a-
mediated signaling pathways that are not simply additive, leading 
to the activation of transcription factors, among them FoxP3 and 
FOXO1, as well as altered interleukin-8 (IL-8) secretion.
MaTerials anD MeThODs
cell culture
Human RPE cells (ARPE-19, LGC Standards/ATCC and pri-
mary human RPE cells) were maintained in DMEM/Ham’s F12 
(Sigma-Aldrich) supplemented with 10% fetal bovine serum 
(FCS; Biochrom or Thermo Fisher Scientific) and 0.5% penicil-
lin/streptomycin (Biochrom or Thermo Fisher Scientific) at 37°C 
in a humidified atmosphere. Cells were switched to serum-free 
medium 24 h prior to experiments.
The isolation of primary RPE cells from human cadaver 
eyes was approved by the ethics committee of the Clinic of the 
University of Munich, Germany, and the methods for securing the 
human tissue were compliant with the Declaration of Helsinki. 
Donor eyes were obtained from the Eye Bank of the Eye Hospital 
(LMU München, Germany) and processed within 24 h after death. 
Isolation of human RPE cells was performed as described (35).
induction of experimental Uveitis in rats
Lewis rats (Lew/Orl Rj) were bred and maintained under 
pathogen-free conditions with water and food ad  libitum and 
used for experiments at the age of 6–8 weeks. All animal experi-
ments were approved by the Review Board of the Regierung 
von Oberbayern (Permit-Number 55.4-1-54-2531-225-2015) 
and conformed to the ARVO Statement on the Use of Animals 
in Ophthalmic and Vision Research. Animals were immunized 
subcutaneously in both hind legs with 100 µl emulsion contain-
ing 15 µg peptide R14 (human IRBP aa 1169–1191; Polypeptide 
Laboratories) and CFA, fortified with Mycobacterium tuberculosis 
strain H37RA (BD Biosciences) to a final concentration of 2.5 mg/
ml. Uveitis was scored clinically by ophthalmoscopy to determine 
inflammation as described (36).
immunofluorescence staining  
of Tissue sections
For histology, rat eyes were embedded in Tissue Tec OCT (Paesel 
and Lorey) and snap frozen in methyl butane (Merck). Air-dried 
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cryosections (8  µm) were post-fixed in ice-cold acetone for 
10 min, stained with hematoxilin (Merck), and graded to obtain 
a pathology score as described (36). For immunofluorescence 
staining, acetone-fixed sections were pre-incubated with PBS 
containing 3% normal rabbit serum and 3% donkey serum for 
15 min at room temperature (RT), washed once with PBS, and 
then incubated with rabbit anti-rat FoxP3 antibody (Novus 
Biologicals, Abingdon, UK; diluted 1:500 in PBS), mouse anti-rat 
TCR-ab-FITC clone R73 (eBioscience, diluted 1:40), or mouse 
anti-rat TCR-gd-FITC clone V65 (Aviva Systems, diluted 1:6) for 
1 h at RT in the dark. Control stainings were performed with sec-
ondary antibody only. After PBS washes, Cy3-conjugated donkey 
anti-rabbit IgG(H + L) (Jackson Laboratories) was added (1:100 
in PBS) and incubated for 1 h at RT in the dark. The slides were 
washed, mounted with Entellan (Merck), imaged with a Zeiss 
Axioskop 2plus (Carl Zeiss), and photographs taken with a Sony 
CyberShot DSC-S70 3.3 mp digital camera.
immunofluorescence staining  
of arPe-19 cells
ARPE-19 cells were grown in chamber slides overnight. Cells 
were washed with PBS/1% BSA and fixed in 4% paraformal-
dehyde for 15 min. Cells were then incubated in FcR blocking 
buffer [1:10 dilution of Fc receptor blocking reagent (Mittenyi 
Biotec GmbH) in PBS/1% BSA] for 10 min on ice, followed by 
incubation with primary antibody mAb C3aR (1:400; Santa Cruz 
Biotechnology) or C5aR (1:400; BioLegend) for 1 h at RT. After 
washing, cells were first incubated with goat anti-mouse Alexa 
Fluor® 488-conjugated secondary antibody (1:600; Thermo 
Fisher Scientific), followed by incubation with DAPI (Sigma, 
Munich, Germany) for 15 min and coverslipping. Pictures were 
taken on an LSM710 microscope (Carl Zeiss AG) using 63x, 1.4 
NA, oil immersion, and ZEN2009 software (Carl Zeiss AG).
calcium imaging
Serum-deprived cells grown on 15 mm glass cover slips (8.5 × 103 
cells/cm2) were incubated for 40  min with 2  µM fura-2/AM 
(F1221, Invitrogen). The cover slips were placed in a custom-
made recording chamber (filled with bath solution consisting of 
(in mM): 138 NaCl, 5.8 KCl, 0.41 MgSO4, 0.48 MgCl2, 0.95 CaCl2, 
4.17 NaHCO3, 1.1 NaH2PO4, 25 HEPES) and imaged using a Zeiss 
Axiovert 40 CFL inverted microscope (Carl Zeiss AG) equipped 
with a 40 × oil immersion objective, a Visichrome High Speed 
Polychromator System (Visitron Systems), and a high-resolution 
CCD camera (CoolSNAP EZ, Photometrics) as described 
previously (19). Experiments were carried out by adding C3a 
(260 nM) and/or C5a agonists (52 nM; Complement Technology, 
Inc.), nifedipine (10 µM; Tocris Biosciences), LY294002 (50 µM; 
Cayman Chemical Company), or API-2 (10  µM; Santa Cruz 
Biotechnology) to the bath solution. Data acquisition and 
analysis were carried out using the MetaFluor Fluorescence Ratio 
Imaging Software (Visitron Systems). Fluorescence intensity of 
Fura-2 was detected at an emission wavelength of 505 nm, while 
the excitation wavelengths were set to 340/380 nm. Changes in 
intracellular free Ca2+ are all given as ratios of the fluorescence of 
the two excitation wavelengths (dF/F) and normalized to baseline 
(ddF/F).
Western Blotting and Dot Blotting
ARPE-19 cells were grown on transwell plates and stimulated 
with C3a and/or C5a agonists. Cells were solubilized in RIPA 
buffer (Thermo Fisher Scientific) containing a cocktail of protease 
and phosphatase inhibitors (Sigma-Aldrich). Whole cell lysates 
were clarified by centrifugation (20,000 × g for 30 min at 4°C), 
and samples were quantified (Pierce BCA protein assay reagent 
kit; Thermo Fisher Scientific). For western blotting, equivalent 
protein amounts were added to Laemmli sample buffer and 
boiled. Samples were separated by electrophoresis on a 4–20% 
Criterion™ TGX™ Precast Gels (Bio-Rad Laboratories, Inc.), and 
proteins were transferred to a PVDF membrane. For Dot Blotting, 
lysates containing equivalent amount of total protein were loaded 
on a 96-well plate (Bio-Dot ® Microfiltration Apparatus; Bio-Rad 
Laboratories Inc.) and vacuum-transferred onto nitrocellulose 
membranes. Membranes were incubated with primary antibod-
ies (1:1,000) against Phospho-Akt (Ser 473), Phospho-FOXO1 
(Ser 256), Phospho-CREB (Ser 133), β-actin, Phospho-CaV1.3 
(all from Cell signaling Technology), or Phospho-FoxP3 (Ser 418; 
Abgent, Inc.) overnight using β-actin or GAPDH (both from Cell 
Signaling Technologies) as controls. Proteins were visualized with 
horseradish peroxidase–conjugated secondary antibodies (Santa 
Cruz Biotechnology), followed by incubation with Clarity™ 
Western ECL Blotting Substrate (Bio-Rad Laboratories, Inc.) 
and chemiluminescent detection. Protein bands or dots were 
scanned, and densities were quantified using ImageJ software.
immunoprecipitation
For immunoprecipitation of calcium channels, ARPE-19 cells 
were extracted by solubilizing cells in RIPA buffer and whole 
cell lysates were clarified as described above. Lysates were pre-
cleared with 25  µl of Protein A-agarose beads (Cell Signaling 
Technology) to remove the non-specific binding proteins, and 
then samples with equivalent protein content were incubated 
with 1 µg of the anti-CaV1.3 antibody (Alomone Labs) overnight 
at 4°C with agitation. Next, 150 µl of Protein A-Agarose beads 
was added to the samples and incubation was continued for 4 
h at 4°C. Immunoprecipitated complexes bound to the beads 
were collected by centrifugation (5,000 × g for 10 min at 4°C), 
washed by resuspension, followed by centrifugation. Finally, each 
pellet was resuspended in 50 µl of Laemmli sample buffer, boiled, 
and centrifuged prior to loading. Samples were then separated 
by electrophoresis, and proteins were transferred to a PVDF 
membrane and blotted for CaV1.3 as described above.
gene expression analysis
Retinal pigment epithelium cells were grown to confluency on 
transwell plates and maintained under serum-free conditions for 
24 h before harvesting. A subset of ARPE-19 cells was stimulated 
with C3a and/or C5a agonists for 24 h. RNA isolation and cDNA 
synthesis were performed using the RNeasy Mini and Quantitect 
Reverse Transcription Kit (Qiagen). The mRNA levels of C3, C3aR, 
C5, FOXO1, and GAPDH (Eurofins Genomics) were measured in 
triplicates by RT-PCR (Rotor-Gene SYBR Green PCR Kit; Qiagen, 
Hilden, Germany) on a Rotor-Gene Q (Qiagen); those of C5aR 
were measured by TaqMan® Gene Expression Assay (Thermo 
Fisher Scientific). For primers, see Table 1. Quantification of the 
TaBle 1 | Primer characteristics.
gene Forward sequence reverse sequence
C3 TTCCGATTGAGGATGGCTCG ATGTCACTGCCTGAGT 
GCAA
C3aR GGCTGTCTTTCTTGTCTGCTG GACTGCCTTGCTTT 
CTTCCTAA
C5 ACACTGGTACGGCACGTATG GGCATTGATTGT 
GTCCTGGG
C5aR1 Hs00704891_s1
FOXO1 TGCATTTCGCTACCCGAGTT GTGGCTGACAAGAC 
TTAACTCAA
GAPDH TCAACGACCACTTTGTC 
AAGCTCA
GCTGGTGGTCCAGGG 
GTCTTACT
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target genes was carried out using the comparative CT (thresh-
old cycle, ΔΔCT) method using Rotor-Gene Q software 2.2.3 
(Qiagen) (37).
cytokine/chemokine secretion
ARPE-19 cells were grown to confluency. After 3  days, cells 
were switched to serum-free medium for 24  h. Then medium 
was exchanged with serum-free DMEM/Ham’s F12, to which 
C3a or C5a or both were added to hexaplicate cultures each for 
3 days. Some cultures with or without complement components 
were additionally supplied with PI3-kinase inhibitor LY294002. 
Supernatants from hexaplicate cultures (two wells each) were 
pooled and tested in triplicates by human Bio-Plex bead analysis 
(Bio-Rad Laboratories, Inc.) and measured using the Bio-Plex 
200 (Bio-Rad Laboratories, Inc.). Tested analytes included 
IL-1beta, IL-1ra, interleukin- 6 (IL-6), IL-8/CXCL8, interleukin- 
10 (IL-10), IL-12(p70), IFN-gamma, monocyte chemotactic 
protein-1 (MCP-1)/CCL2, and VEGF.
Monocytes were isolated from blood of three different healthy 
male donors using indirect magnetic labeling separation (MACS 
pan monocyte isolation kit, Miltenyi Biotec). 1 × 105 cells were 
incubated with C3a (3.3 µM), C5a (480 nM), or both in a 96-well 
plate at 37°C for 20  h. Supernatants were collected, and inter-
leukins (IL-1β, IL-6, and IL-10) were measured using ELISA 
(Ready-Set-Go® ELISA kits, eBioscience, Inc.).
Facs analysis
6 × 105 human primary monocytes were incubated with BSA, 
C3a (3  µM, Complement Technology, Inc.), or C5a (0.6  µM, 
Complement Technology, Inc.) for 5  min at 37°C. Cells were 
then washed with PBS and bound with monoclonal antibody 
anti-CD88 (anti-C5aR, 1:200, BioLegend) for 1 h on ice. Cells 
were washed afterward and incubated with corresponding 
goat anti-mouse Alexa Fluor® 647-conjugated secondary 
antibody (1:400, Invitrogen) for 30  min on ice in the dark. 
Cells were washed with PBS and diluted in 300 µl PBS. FACS 
measurement was carried out with BD LSR II flow cytrometry 
(BD Biosciences).
statistical analysis
All data are presented as mean values ± SEM or ±SD. Statistical 
significance was calculated using Mann–Whitney U test for 
Ca2+-Imaging analyses and protein secretion analyses. For west-
ern blot and gene expression analyses, Student’s t-test was used (p 
values *p < 0.05, **p < 0.01, and ***p < 0.005). All calculations 
were performed in SPSS 22 and Excel 2010.
resUlTs
Properties of anaphylatoxin-evoked ca2+ 
responses by rPe cells
C3aR and C5aR mRNAs are expressed in the RPE cell line 
ARPE-19 (Figures 1A,C) as well as primary human RPE cells 
(Figures  1B,C), and protein expression was confirmed in 
ARPE-19 cells (Figure  1D). The most common intracellular 
response triggered by the engagement of C3aR or C5aR is the 
mobilization of calcium. Here, we demonstrated functional 
signaling of both receptors in ARPE-19 cells in response to the 
application of C3a and C5a, which resulted in a biphasic increase 
in intracellular free Ca2+, composed of an initial peak after ~90 s 
and a plateau phase that is reached after ~3  min (Figure  1E, 
left panel). The response to C5a reached a 2x larger peak and 
plateau phase than the C3a response (Figure 1E, right panel). 
In vivo, the RPE is separated from the blood stream by Bruch’s 
membrane, making it impossible to predict the concentration 
of anaphylatoxins that potentially reach the RPE. Thus, we 
adjusted the anaphylatoxin contractions used for experiments 
to the known receptor binding constants. The anaphylatoxin 
concentrations used (260 nM C3a and 52 nM C5a) were close 
to saturation (38, 39).
In the presence of sufficient C3 and C5, C5a production 
follows that of C3a in very short succession during the activation 
of the cascade. To investigate whether there is an interaction of 
C3a- and C5a-dependent signaling, C3a and C5a were added 
simultaneously to cells. Co-application also led to a biphasic 
elevation of intracellular free Ca2+ (Figures  2A–C), following 
the same temporal profile like individual applications. However, 
the response to simultaneously applied anaphylatoxins was not 
significantly different compared to that of C5a alone (Figure 2A, 
left panel), but it was significantly higher when compared to the 
single C3a application (Figure 2B). These data suggest that the 
two anaphylatoxin receptors do not act in an additive manner, 
but the response is primarily driven by C5aR activity alone. Since 
the two anaphylatoxins are produced in succession rather than 
simultaneously, we applied them in sequence: C3a was applied 
first, and after the Ca2+ response reached a steady state, C5a was 
applied (Figure 2C). Interestingly, under these conditions, C5a 
significantly reduced the steady-state Ca2+ level that has been 
reached by the previous C3a application (ddF/F at time point of 
C5a application: 0.763; ddF/F 30 s after C5a application: 0.746; 
p <  0.001). The consecutive signaling of C3a and C5a reached 
a plateau phase that was significantly lower than that observed 
with simultaneous application (Figure 2C). The response to the 
consecutive application of C3a and C5a was not significantly 
different from that of the single C3a application (Figure  2D). 
Incubation of human monocytes with C3a did not change 
C5aR surface expression measured by means of FACS analysis 
(Figure S1 in Supplementary Material). This second set of data 
FigUre 1 | Retinal pigment epithelium (RPE) cells express functional anaphylatoxin receptors C3aR and C5aR. (a) RT-PCR from ARPE-19 cells showing the 
expression of C3, C5, and C3aR mRNA. (B) RT-PCR from human native RPE cells showing the expression of C3, C3aR, C5, and FOXO1. (c) Mean Ct-values of 
qPCR from ARPE-19 cells and human native RPE cells showing the expression of C5aR1. (D) Immunofluorescence staining of ARPE-19 cells for surface expression 
of C3aR and C5aR with primary monoclonal antibodies detecting C3aR or C5aR1 and secondary green fluorescent antibody (Alexa Fluor® 488). Control: secondary 
antibody only. Nuclear DNA is stained with DAPI. Size marker = 10 µm. (e) Left panel: time course of anaphylatoxin-evoked Ca2+ transients in ARPE-19 cells. The 
black rim indicates the SEM. C3a/C5a are added at the start of the displayed Ca2+ transient. Arrows mark time points taken for statistical analysis: the peak and the 
sustained phase (3 min after peak = late phase). Right panel: statistical analysis of the effects of C3a and C5a application on intracellular free Ca2+ in ARPE-19 cells 
at peak and late phases, normalized to baseline ratio (ddF/F). Anaphylatoxins were applied at concentrations of 260 nM (C3a) and 52 nM (C5a). Please note that all 
other figures depicting Ca2+ transients are laid out and analyzed in the fashion described here. Data are mean + SEM from two to six independent experiments; 
number of cells is indicated in the bars, ***p < 0.005 (Mann–Whitney U test).
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further indicates that C3aR and C5aR do not act in an additive 
manner or in concert but rather regulate each other, with C3aR 
engagement presumably preventing a future C5aR response.
intracellular signaling Mechanisms of 
anaphylatoxin-evoked ca2+ responses
Next, we studied whether the anaphylatoxin-evoked Ca2+ 
responses involve known mechanisms of the anaphylatoxin 
receptor downstream signaling cascades. In immune cells, C3aR 
signals through the pertussis toxin-sensitive G-proteins, and 
C5aR signals through the pertussis toxin-sensitive alpha units 
Gαi2 or the pertussis toxin-insensitive Gα16 (28). Subsequent 
downstream signaling includes mainly the activation of PI3-
kinase, followed by the activation of Akt (27), leading to calcium 
mobilization from intracellular stores (28). In RPE cells, we 
have shown that NHS leads to strong activation of L-type Ca2+ 
channels, allowing for the influx of extracellular calcium (19). 
In order to study these potential mechanisms of anaphylatoxin 
signaling, we used different pathway-specific blockers. The PI3-
kinase blocker LY294002, the Akt blocker API-2, or the L-type 
Ca2+ channel blocker nifedipine was added to the cells prior to 
stimulation. LY294002 is a pan-isoform PI3K blocker, which was 
used since the specific PI3K isoforms involved in ion channel 
regulation have not yet been identified. LY294002, API-2, and 
nifedipine had little effect on the C3a-evoked Ca2+ responses 
during both the peak and late phases (Figures  3A,C,G), 
although the Akt blocker API-2 surprisingly increased the 
C3a-evoked Ca2+ response at the peak phase (Figures 3B,G). In 
contrast, LY294002 decreased the Ca2+ response at both the peak 
and plateau phases upon application of C5a (Figures 3D,H). In 
addition, the Akt blocker API-2 reduced the C5a-evoked Ca2+ 
rises, although only during the peak but not the plateau phase 
(Figures  3E,H, peak: p =  0.001). Thus, PI3-kinase and Akt1 
signaling participate in C5a-evoked Ca2+ responses, in which 
FigUre 2 | Interactive signaling between C3a and C5a stimulation observed in calcium transients. The time courses of anaphylatoxin-evoked Ca2+ transients in 
ARPE-19 cells were examined in cells exposed to anaphylatoxins alone or in combination (left panels), and peak and late phase amplitudes were analyzed (right 
panels). Simultaneous (a,B,c) versus consecutive (c,D) applications were tested. (a) Single application of C5a compared to the simultaneous co-application of 
C3a and C5a. (B) Single application of C3a compared to the simultaneous co-application of C3a and C5a. (c) Simultaneous co-application of C3a and C5a 
compared to consecutive application, where C5a was applied after C3a when the Ca2+ transient has reached a steady state indicated by arrow. (D) Single 
application of C3a compared to consecutive co-application of C3a followed by C5a. Anaphylatoxins were applied at concentrations of 260 nM (C3a) and 52 nM 
(C5a). Data are presented as mean values + SEM. Numbers of cells tested in two to seven independent experiments is indicated in the bars, *p < 0.05, 
***p < 0.005 (Mann–Whitney U test).
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both contribute to the peak, but only PI3-kinase contributes to 
the plateau phase. Finally, we have previously shown that L-type 
Ca2+ channels partly contribute to the plateau phase of the Ca2+ 
signal in response to NHS (19). Furthermore, PI3-kinase is 
known to stimulate L-type channels (40). However, in the pres-
ence of nifedipine, the C3a-evoked response was unaffected, 
whereas the C5a-evoked Ca2+ response was weakly reduced 
with a small but significant reduction at the peak, but not at the 
plateau phase (Figures 3F,H).
These Ca2+ imaging data indicate the involvement of the cen-
tral intracellular signaling molecule Akt in anaphylatoxin-evoked 
Ca2+ responses. To confirm the conclusions derived from our 
pharmacological interventions, we investigated whether Akt is 
activated and phosphorylated in response to the anaphylatoxins. 
Phosphorylation of Akt at serine 473, required for full activation 
of its kinase activity, was determined by western blot analysis. 
The ratios of phosphorylated Akt to β-actin were calculated, and 
slopes of change were determined (Figure  4A). C3a, C5a, and 
combined C3a/C5a application induced Akt phosphorylation 
significantly after 15 min (Figure 4A); however, when C3a and 
C5a were applied simultaneously, Akt phosphorylation was 
reduced below the levels obtained by single application of either 
C3a or C5a. Thus, although each anaphylatoxin activated Akt, 
in combination, the activation of Akt was reduced. These results 
further confirm the non-additive C3aR and C5aR signaling 
pathways.
Studying the phosphorylation of the L-type Ca2+ channel 
subunit CaV1.3 under anaphylatoxin stimulation revealed 
(Figure 4B) an increase in CaV1.3 phosphorylation upon C3a, 
C5a, or combined C3a/C5a application after 15 min (Figure 4B). 
CaV1.3 phosphorylation was increased upon C5a compared 
to C3a, but combined C3a and C5a application resulted in 
phosphorylation levels lower than those with C3a alone. These 
data are in agreement with our previous experiments using 
complement-sufficient NHS, which revealed CaV1.3 phospho-
rylation upon serum exposure and again suggest the presence 
of competing signaling pathways between C3aR and C5aR 
activation.
FigUre 3 | Role of PI3-kinase and Akt in anaphylatoxin-evoked Ca2+ transients. (a,D) Effect of the PI3-kinase blocker LY294002 (50 µM) on C3a-evoked (a) or 
C5a-evoked (D) Ca2+ transients in ARPE-19 cells. (B,e) Effect of the Akt blocker API-2 (10 µM) on C3a-evoked (B) or C5a-evoked (c) Ca2+ transients in ARPE-19 
cells. (c,F) Effect of the L-type channel blocker nifedipine (10 µM) on C3a-evoked (c) or C5a-evoked (F) Ca2+ transients in ARPE-19 cells. (g,h) Statistical 
comparison of blocker application effects on C3a-evoked (g) and C5a-evoked (h) Ca2+-transients at the peak and late phases. Anaphylatoxins were applied at 
concentrations of 260 nM (C3a) and 52 nM (C5a). (a–F) Black rim indicates SEM. (g,h) data are mean + SEM, number of cells as indicated in the bars from six to 
nine independent experiments, *p < 0.05, ***p < 0.005 (Mann–Whitney U test).
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anaphylatoxin-Dependent changes  
in the Transcription Factor activation  
in arPe-19 cells
In order to evaluate the longer term impact of anaphylatoxins 
on RPE function, we investigated changes in transcription factor 
activation. Since C3a and C5a trigger Ca2+ elevations, an increased 
phosphorylation of the transcription factor Ca2+-dependent 
CREB (cAMP/Ca2+ response element binding protein) (41, 42) 
was expected. C3a or C5a or the combination of C3a/C5a sig-
nificantly increased CREB phosphorylation over a time course 
of 15 min (Figure 5A); however, the degree of phosphorylation 
or the slope did not differ between C3a, C5a, or combined C3a/
C5a stimulation.
Activation of T-cells via the anaphylatoxin receptors results 
in the expression and activation of transcription factors FoxP3 
and/or FOXO1 (43). Surprisingly, FoxP3 and FOXO1 expres-
sion was identified in ARPE-19 cells by dot-blot or western 
blot analysis (Figures  5B,C). FoxP3 is regarded as a marker 
of regulatory T-cells and is transiently expressed in activated 
human and rat effector T-cells (30, 44). FoxP3 protein expres-
sion in RPE cells was confirmed by immunohistochemistry 
in rat retina. FoxP3 was identified in the RPE of rat eyes with 
uveitis, but not in RPE cells of healthy control retinas 
(Figure  5D). Immunohistochemistry for alpha/beta and 
gamma/delta T-cell receptors confirmed that the detected 
FoxP3 protein was indeed localized to RPE and not to infil-
trating T-cells (Figure S2 in Supplementary Material). During 
harvesting of the eyes, the choroidal blood vessels in the eyes 
are drained due to the persisting intraocular pressure; hence, 
no TCR-positive cells can be observed in the choroid unless 
there is focal choroidal inflammation. Eyes were collected after 
resolution of the peak of inflammation, when infiltrating T-cells 
are a rare event. Nevertheless, some remaining T-cells were still 
detected in the retina (Figure S2B in Supplementary Material), 
which did not express FoxP3, suggesting that they were neither 
activated nor regulatory T-cells.
Next, we asked whether anaphylatoxin receptor stimulation 
leads to activation of FoxP3 and/or FOXO1 in ARPE19 cells. 
Phosphorylation at serine 418 affects the transcriptional activity 
of FoxP3, whereas phosphorylation of serine 256 is critical for 
FOXO1. C3a, C5a, and combined C3a/C5a application signifi-
cantly induced FoxP3 phosphorylation after 15 min (Figure 5B).
FigUre 4 | Effects of anaphylatoxins on Akt and L-type Ca2+ channel phosphorylation in ARPE-19 cells. (a) Akt phosphorylation at serine in position 473 was 
examined in ARPE-19 cells treated with C3a, C5a, or the combination of C3a/C5a at 1, 5, 10, and 15 min and compared to unstimulated (designated as 0 min) 
cells. Akt phosphorylation levels were normalized to β-actin (relative p-Akt levels), and slopes of the time course were determined. (B) L-type Ca2+ channel (CaV1.3 
subunit) phosphorylation was examined at the 15-min time point after immunoprecipitation with anti-CaV1.3 and blotting for phosphor-tyrosine. CaV1.3 
phosphorylation levels were normalized to β-actin (relative CaV1.3 levels). Anaphylatoxins were applied at concentrations of 300 nM (C3a) and 50 nM (C5a).  
Data are mean + SEM, n = 3, *p < 0.05, **p < 0.01 (Student’s t-test).
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FoxP3 phosphorylation was rapidly induced by C3a and even 
more so by C5a (Figure 5B). The combination of C3a and C5a did 
not further increase FoxP3 phosphorylation than triggered by C5 
alone (Figure 5B). FOXO1 phosphorylation was also induced by 
either C3a, C5a, or combined C3a/C5a application (Figure 5C). 
Stimulation with C5a induced higher FOXO1 phosphorylation, 
resulting in steeper slopes than that induced by C3a (p < 0.001). 
The combined C3a/C5a application increased FOXO1 phospho-
rylation even further. In conclusion, the anaphylatoxins induced 
activation of transcription factors FoxP3 and FOXO1 via their 
respective receptors. Since CREB was also activated (Figure 5A), 
the anaphylatoxin-dependent changes in gene expression are 
likely Ca2+-dependent.
anaphylatoxin-Dependent changes  
in arPe-19 cell Function
In order to further investigate the consequences of anaphylatoxin 
receptor signaling, we studied changes in mRNA expression of 
selected target genes as well as chemokine and cytokine secre-
tion. As we have shown previously that C3aR activation controls 
gene expression of C3 under pathological conditions (45), we 
examined anaphylatoxin-dependent changes in gene expression 
of C3 and C5 as well as the expression of C3aR and C5aR by 
qPCR (Figure  6). Overall, anaphylatoxin stimulation of ARPE 
cells did not affect the expression of these four genes, apart from 
the combined application of C3a and C5a, which decreased C3 
expression when compared with the unstimulated control or 
stimulation by C3a alone.
We further examined the secretory phenotype of ARPE-19 cells 
after treatment with anaphylatoxins (Figure 7A) by investigating 
the secretion of cytokines using multiplex technology. Of the 
analytes investigated, only secretion of IL-8, MCP-1, and VEGF 
could be verified. A significant increase in IL-8 and VEGF-A 
secretion was induced by co-administration of C3a and C5a, 
but not when each anaphylatoxin was used alone (Figure 7A); 
secretion of MCP-1 was not affected by anaphylatoxin treatment. 
The secretion of MCP-1, VEGF-A, and IL-8, whether constitu-
tive or anaphylatoxin-induced, was almost completely blocked 
by the application of LY294002, indicating a dependence of their 
secretion on the activity of PI3-kinase. Taken together, C3a- and 
C5a-induced changes in intracellular Ca2+, FOXO1, and FoxP3 
activation and secretion of cytokines suggest an immune cell-like 
profile of ARPE-19 cells.
Next, we asked whether similar C3aR- and C5aR-mediated 
signaling interactions can also be identified in immune cells 
such as monocytes. In these experiments, we used higher ana-
phylatoxin concentrations than those in experiments with RPE 
cells. Reasons for that are monocytes are directly exposed to 
blood-derived anaphylatoxins, which reach higher concentra-
tions. Thus, we calculated the anaphylatoxin concentrations 
based on the published C3 and C5 concentrations in human 
serum. We determined the secretion of IL-1β, IL-6, and IL-10 
from freshly isolated human blood monocytes, which are known 
FigUre 5 | Effects of anaphylatoxins on transcription factor phosphorylation in ARPE-19 cells. (a–c) Protein phosphorylation of (a) CREB (Ser133); (B) FoxP3 
(Ser418); and (c) FOXO1 (Ser256) was examined in ARPE-19 cells treated with C3a, C5a, or the combination of C3a/C5a at 1, 5, 10, and 15 min. Phosphorylation 
levels were normalized to β-actin (relative p-protein levels), and slopes of the time course were determined. Anaphylatoxins were applied at concentrations of 
300 nM (C3a) and 50 nM (C5a). Data are mean + SEM, n = 3, *p < 0.05, ***p < 0.001 (Student’s t-test). (D) Immunofluorescence staining of FoxP3. Upper panel: 
Lewis rat (albino) eye with experimental uveitis; lower panel: normal rat eye. Asterisks mark immune cells infiltrating the retina from the choroid through the retinal 
pigment epithelium (RPE) in the eye with uveitis (clinical score of 2, histological score of 1).
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to be regulated by anaphylatoxins (46) (Figure 7B). Secretion of 
the three cytokines was increased upon application of C3a or C5a 
alone, with a 2–3x stronger increase by C5a. Co-application of 
C5a together with C3a suppressed the secretion of IL-1β or IL-10 
to a level below that induced by stimulation with C5a only, but not 
below the levels obtained with C3a stimulation alone. Altogether, 
ARPE-19 and monocytes showed similar activation pattern by the 
anaphylatoxins. In both cases, C5a induced stronger responses 
than C3a, and interfering effects were observed when the cells 
were co-stimulated with C3a and C5a. Parallel experiments with 
monocytes using the same anaphylatoxin concentrations used 
with RPE cells revealed the same effects on cytokine secretion, 
although to a lesser degree (Figure S1 in Supplementary Material).
DiscUssiOn
The main results of the current study are: (1) Human RPE expres-
ses C3aR and C5aR and (2) responds to anaphylatoxin stimula-
tion with a characteristic slow increase in free cytosolic Ca2+. (3) 
The intracellular Ca2+ increase in response to C5aR stimulation 
FigUre 6 | Effects of anaphylatoxins on gene expression of C3, C3aR, C5, 
and C5aR in ARPE-19 cells. Quantitative PCR analysis of the anaphylatoxin-
dependent regulation of complement factor gene expression for C3 (upper 
left panel), C3aR (upper right panel), C5 (lower left panel), and C5aR (lower 
right panel). Anaphylatoxins were applied at concentrations of 52 nM (C3a) 
and 52 nM (C5a). Data are expressed as mean values + SEM, n = 3, 
*p < 0.05, ***p < 0.005 (Student’s t-test).
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involves PI3-kinase-Akt signaling with weak contribution of 
the L-type calcium channel. The molecular signaling pathways 
leading to a rise in free Ca2+ in response to C3aR stimulation 
remain unclear. (4) In response to anaphylatoxin stimulation, 
Akt-dependent FoxP3 and FOXO1 phosphorylation is induced, 
(5) and the intracellular Ca2+ increase correlates with increased 
CREB phosphorylation. (6) Finally, complement gene expression 
is not altered in response to anaphylatoxin stimulation, but secre-
tion of IL-8 and VEGF-A increases in response to co-application 
of C3a and C5a. (7) Overall, in both ARPE-19 and monocytes, 
C3a-elicited responses are weaker compared to those elicited 
by C5a. (8) In most cases, responses are either driven by C5a 
(C3a +  C5a =  C5a) or are smaller than those elicited by C3a 
alone (C3a +  C5a <  C3a). In summary, our data suggest that 
the RPE shares certain characteristics with immune cells (FoxP3 
expression, cytokine secretion), confirming its role in the “immu-
noregulatory” gate (47–49); the RPE thus actively contributes 
to the establishment of a pro-inflammatory environment in the 
presence of complement activation. The differential responses to 
single and co-administration of anaphylatoxins allows for graded 
responses by the RPE. As C5aR engagement usually dominates 
and/or reverses C3a-receptor-mediated responses, anaphylatoxin 
signaling should be tested within the context of the intact complete 
complement system.
Although a large body of evidence describes a prominent 
role for chronic local complement activation in AMD, and the 
presence of anaphylatoxins in pathological structures of the RPE 
have been described (25), the impact of complement proteins 
on the RPE has not yet been investigated carefully. To date, 
research has focused mostly on the effects of the TCC or MAC on 
cellular readouts (26). Initially, while C3aR and C5aR could not 
be demonstrated in the RPE by immunohistochemistry (50), 
gene expression data in ARPE-19 cells (13) as well as our data 
from primary human RPE cultures and our unpublished micro-
array analyses on RPE/choroid from C57BL/6J mice (U74Av2, 
Affymetrix; C3aR, p = 0.001; C5aR, p = 0.05) suggest that both 
receptors are expressed. Functionally, we have previously shown 
that RPE cells do respond to complement activation products 
by analyzing the ionic mechanisms of complement-evoked 
Ca2+ signals. Using C3- or C5-depleted sera, we found specific 
contributions of anaphylatoxins to Ca2+-signaling (19). Here, we 
looked in more detail by investigating the anaphylatoxin-evoked 
rises in intracellular free Ca2+ as a second messenger in the 
absence of other confounding NHS components. Both C3a and 
C5a increased intracellular Ca2+, with the C5a responses being 
about 2x as those elicited by C3a. The C5a-driven Ca2+-signal 
required the activation of PI3-kinase and Akt, as demonstrated 
by pharmacological intervention or by direct assessment of either 
Akt or PI3-kinase phosphorylation. These data are in accordance 
with other studies that have investigated either C5aR or C3aR 
activation in immune cells (28). Since the PI3K-isoforms that 
specifically regulate ion channel activation and thus Ca2+ signals 
have so far not been identified, we used LY294002 as a pan PI3-
kinase blocker. It is likely that anaphylatoxin-activated pathways 
involve different PI3K-isoforms for ion channel regulation and/
or for transcription factor activation. However, deciphering these 
complex interactions would require its own study.
We have previously shown that NHS generated Ca2+ elevations 
that are mainly driven by the activation of voltage-dependent 
L-type Ca2+ channels at the initial peak and a following plateau 
phase. This goes along with increased phosphorylation of the pore-
forming CaV1.3 subunit (15, 17, 19). Furthermore, the activation 
of L-type channels represents an important prerequisite for the 
effects observed by sub-lytic MAC on RPE cells, especially their 
increased secretion of VEGF (15, 17). In comparison, we here show 
that C3a-evoked Ca2+ responses were unaffected by the L-type 
channel blocker nifedipine, whereas the peak response elicited by 
C5a was significantly reduced; nifedipine in the presence of both 
C3a and C5a was not tested. Nevertheless, the phosphorylation 
of the L-type channel pore-forming subunit CaV1.3 was increased 
by both anaphylatoxins alone, or in combination. Finally, similar 
to the stimulation in NHS (12), C3a and C5a together increased 
VEGF secretion in ARPE-19 cells. Taken together, the majority 
of readouts triggered by NHS (Ca2+-signal and its susceptibility 
to nifedipine blockage, CaV1.3 phosphorylation, and VEGF secre-
tion) were replicated by co-administration of C3a and C5a and 
in some instances by C3a or C5a alone. Since C3a or C5a alone 
did not generate the L-type channel-dependent Ca2+-signal like 
in NHS, other complement cascade components, especially the 
TCC/MAC, may participate in NHS-dependent Ca2+ signaling.
This complexity of the complement system is reflected in the 
results of our experiments, which revealed interactions between 
intracellular signaling pathways triggered by C3aR and C5aR. 
FigUre 7 | Effects of anaphylatoxins on cytokine and growth factor secretion by ARPE-19 cells and human monocyctes. (a) Secretion of interleukin-8 (IL-8), 
vascular endothelial growth-factor-A (VEGF-A), and monocyte chemotactic protein-1 (MCP-1) by ARPE-19 cells stimulated with C3a, C5a, or both was examined, 
relative to the values measured in the absence of anaphylatoxins (control; control was arbitrarily set as 1). Co-application of LY294002 (50 µM) with the different 
anaphylatoxins (C3a: 260 nM; C5a: 52 nM, or combined C3a/C5a: 260/52 nM) was used to test whether constitutive or induced secretion required PI3-kinase 
activation. (B) Secretion of interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and interleukin-10 (IL-10) was tested in human monocytes stimulated with C3a (3.3 µM), 
C5a (480 nM), or both when compared with buffer alone. Level of cytokine induction by C5a was arbitrarily set as 1. Data are expressed as mean values ± SD; 
n = 3; *p < 0.05; **p < 0.01, ***p < 0.005 [(a) Mann–Whitney U test, (B) Student’s t-test].
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Calcium imaging allowed for the most careful dissection of 
the anaphylatoxin-evoked signals. Those experiments showed 
that C3a and C5a each elicited a Ca2+ response, but when co-
administered, the response was not additive, but rather appeared 
to be limited in amplitude to the response elicited by C5a alone. 
When administered sequentially, C5a was found to reduce the 
already established C3a response, rather than increasing it. Given 
the above-indicated multitude of involved intracellular signal 
molecules, this interaction between C3a and C5a signaling might 
occur on a variety of different levels between ionic mechanisms 
and kinases. The most obvious mechanism, an acute decrease 
of C5aR surface expression induced by C3a, was ruled out by 
analysis of C5aR expression after C3a stimulation in human 
monocytes (Figure S1 in Supplementary Material).
The activation of CREB, which is known to transduce Ca2+ 
elevations into changes in gene expression (41, 42), suggests that 
this pathway might play a significant role; however, differential 
effects between C3a, C5a, and the combined exposure on CREB 
were not identified. The generation of anaphylatoxin-evoked Ca2+ 
signals in immune cells has been shown to activate the transcrip-
tion factors FOXO1 and FoxP3 to change the activation status 
of the cell (27, 28). Similarly, here, we found phosphorylation 
of FOXO1 and FoxP3 in RPE cells as a result of anaphylatoxin 
receptor stimulation. FoxP3 phosphorylation showed the same 
profile as the Ca2+ signal; the C3a-driven phosphorylation 
was smaller in magnitude than that driven by C5a, and when 
co-administered, the response was again limited in amplitude to 
the response elicited by C5a alone. This is in contrast to FOXO1 
phosphorylation, which showed an additive effect.
These anaphylatoxin-mediated changes in the RPE resulting 
in changes in ionic composition and activation of transcription 
factors might lead to profound changes in RPE function. While 
no changes were observed in gene expression levels of C3, C5, or 
the two anaphylatoxin receptors after stimulation of C3a or C5a 
alone, the combined C3a/C5a stimulation reduced C3 expression 
when compared with control. Similarly, no significant changes 
were observed for the secretion of IL-8 and VEGF after stimula-
tion with C3a or C5a alone, but the combined C3a/C5a stimula-
tion significantly increased IL-8 and VEGF levels when compared 
with control. We propose that the combined activation of C3aR 
and C5aR triggers the reactivity of RPE cells to inflammation, 
but not when individual receptor systems are activated separately.
A surprising finding in our study is FoxP3 expression and 
phosphorylation in response to anaphylatoxin stimulation in 
RPE cells. FoxP3 protein expression has been postulated to be 
restricted to T lymphocytes (30, 44, 51); to our knowledge, this is 
the first report that this protein is detected in other cells. While 
FoxP3 was not detected in native human RPE or in healthy rat 
eyes, under inflammatory conditions such as during experimen-
tal uveitis, FoxP3 protein expression was detected in rat RPE 
cells. Phosphorylation of FoxP3 in ARPE-19 cells in response 
to stimulation with anaphylatoxins supports a role for FoxP3 
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as a reaction to dangerous events. Whether FoxP3 expression 
in stressed RPE cells allows them to acquire a regulatory cell 
phenotype to protect the retina from inflammatory insults and to 
maintain the ocular immune privilege or facilitate the crosstalk 
with the immune system under potentially dangerous conditions 
will be investigated in future experiments.
In general, signaling via C3aR is reported to trigger regen-
erative, protective, and anti-inflammatory responses, whereas 
signaling via C5aR triggers immune cell recruitment and inflam-
mation (28). These conclusions are supported by animal studies 
using application of anaphylatoxins and knock-out mouse 
models (51–57). Here, we have identified mechanisms that could 
mediate the different reactions of the RPE in response to C3a, 
C5a, and the combination of C3a/C5a; in particular, our data 
suggest that C3aR engagement prevents further C5aR responses, 
possibly favoring C3a-dependent effects. This mechanism is 
supported by data analyzing end organ damage in C3aR- and 
C5aR-deficient mice. C3aR deficiency did not or only marginally 
reduce end organ damage, whereas the C5aR-deficient mice in 
some cases even showed augmented regeneration. However, the 
C3aR/C5aR-double knock-out phenotype did not reproduce 
C5aR-dominated effects on tissue destruction, but instead 
showed less severe organ damage than the C3aR single knock-
out (51–57).
In summary, we conclude that the RPE behaves in part like an 
immune cell in its reaction to anaphylatoxin exposure. Thus, we 
suggest that the special integrative signaling between C3aR and 
C5aR helps the RPE to precisely adopt its immune-suppressive 
function. This may lead to a new understanding of the chain of 
events leading to AMD.
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FigUre s1 | (a) Secretion of interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and 
interleukin-10 (IL-10) was tested in human monocytes stimulated with C3a 
(330 nM), C5a (48 nM), or both when compared with buffer alone. Level of 
cytokine induction by C5a was arbitrarily set as 1. Data are expressed as mean 
values ± SD; n = 3; *p < 0.05, Student’s t-test. (B) FACS analysis of C5aR 
surface expression in human monocytes after stimulation with BSA (gray), C3a 
(3 µM, green), or C5a (0.6 µM, red).
FigUre s2 | (a) Cryosections of rat eye with experimental uveitis induced by 
immunization as described and double stained for TCR-αβ and -γδ as well as 
FoxP3 expression. Left side (I, III): FoxP3-Cy3 staining (red), right side (II, IV): 
TCR-αβ/γδ-FITC staining (green). Upper panel: T cells (arrows) infiltrating the 
retina (II), but no concomitant FoxP3 staining [I, retinal pigment epithelium (RPE) 
was destroyed during uveitis]. Lower panel: FoxP3 staining of the RPE (asterisk) 
after peak disease (III), no more T cell infiltrates visible (IV). (B) Control 
immunofluorescence staining of a Lewis rat (albino) eye section with experimental 
uveitis: secondary Cy3-labeled donkey anti-rabbit IgG antibody only. RPE is 
identified by an asterisk. (c) FoxP3 antibody-positive control: rat spleen section 
stained for FoxP3 expression. G = germinal centers surrounded by FoxP3-
positive cells.
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